CONTEGO MEDICAL, INC.
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2005-01-01
- Employees
- 11
- Market Cap
- -
Clinical Trials
5
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Direct Access Carotid Artery Stenting Using the Neuroguard IEP System (PERFORMANCE III)
- Conditions
- Carotid Artery DiseasesCarotid Stenosis
- First Posted Date
- 2023-05-06
- Last Posted Date
- 2025-07-11
- Lead Sponsor
- Contego Medical, Inc.
- Target Recruit Count
- 178
- Registration Number
- NCT05845710
- Locations
- 🇺🇸
Honor Health, Scottsdale, Arizona, United States
🇺🇸Hartford Hospital, Hartford, Connecticut, United States
🇺🇸MedStar Washington Hospital Center, Washington, District of Columbia, United States
Protection Against Emboli During Carotid Artery Stenting Using the Neuroguard IEP System
- Conditions
- Carotid Artery DiseasesCarotid StenosisCarotid Artery Stenosis
- First Posted Date
- 2019-12-17
- Last Posted Date
- 2024-06-06
- Lead Sponsor
- Contego Medical, Inc.
- Target Recruit Count
- 305
- Registration Number
- NCT04201132
- Locations
- 🇺🇸
Huntsville Hospital, Huntsville, Alabama, United States
🇺🇸St. Helena Hospital, Saint Helena, California, United States
🇺🇸MedStar Washington Hospital Center, Washington, District of Columbia, United States
Evaluation of the 3-in-1 Neuroguard IEP System for Carotid Artery Stenosis
- Conditions
- Carotid Artery Stenosis
- First Posted Date
- 2019-10-29
- Last Posted Date
- 2022-11-21
- Lead Sponsor
- Contego Medical, Inc.
- Target Recruit Count
- 67
- Registration Number
- NCT04142541
- Locations
- 🇩🇪
Sankt Gertrauden-Krankenhaus GmbH, Berlin, Germany
🇩🇪Cardiovascular Centre Frankfurt, Frankfurt, Germany
🇩🇪Medizinisches Versorgungszentrum, Hamburg, Germany
Study to Evaluate the Lower Extremity Intervention With Integrated Embolic Protection Using the Vanguard IEP System
- Conditions
- Peripheral Arterial DiseaseIntermittent ClaudicationAtherosclerosis of Femoral Artery
- First Posted Date
- 2017-09-05
- Last Posted Date
- 2019-07-10
- Lead Sponsor
- Contego Medical, Inc.
- Target Recruit Count
- 113
- Registration Number
- NCT03271710
- Locations
- 🇧🇪
OLV Hospital Aalst, Aalst, Belgium
🇧🇪Imelda Hospital / Vascular Science Research Center, Bonheiden, Belgium
🇧🇪AZ Sint Blasius, Dendermonde, Belgium
A Multi-Center Study to Evaluate Acute Safety and Clinical Performance of Paladin® Carotid Post-Dilation Balloon System With Integrated Embolic Protection
- Conditions
- Carotid Artery Stenoses
- First Posted Date
- 2015-07-17
- Last Posted Date
- 2022-11-21
- Lead Sponsor
- Contego Medical, Inc.
- Target Recruit Count
- 106
- Registration Number
- NCT02501148
- Locations
- 🇩🇪
Universitäts-Herzzentrum Bad Krozingen, Bad Krozingen, Germany
🇩🇪Sankt Gertrauden Krankenhaus, Berlin, Germany
🇩🇪CardioVascular Centre Frankfurt, Frankfurt, Germany